Cargando…
Stable Benzotriazole Esters as Mechanism-Based Inactivators of the Severe Acute Respiratory Syndrome 3CL Protease
Severe acute respiratory syndrome (SARS) is caused by a newly emerged coronavirus that infected more than 8000 individuals and resulted in more than 800 fatalities in 2003. Currently, there is no effective treatment for this epidemic. SARS-3CL(pro) has been shown to be essential for replication and...
Autores principales: | Wu, Chung-Yi, King, Ke-Yung, Kuo, Chih-Jung, Fang, Jim-Min, Wu, Ying-Ta, Ho, Ming-Yi, Liao, Chung-Lin, Shie, Jiun-Jie, Liang, Po-Huang, Wong, Chi-Huey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111201/ https://www.ncbi.nlm.nih.gov/pubmed/16638531 http://dx.doi.org/10.1016/j.chembiol.2005.12.008 |
Ejemplares similares
-
Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic α,β-unsaturated esters
por: Shie, Jiun-Jie, et al.
Publicado: (2005) -
A Structural View of the Inactivation of the SARS Coronavirus Main Proteinase by Benzotriazole Esters
por: Verschueren, Koen H.G., et al.
Publicado: (2008) -
Structural basis of mercury‐ and zinc‐conjugated complexes as SARS‐CoV 3C‐like protease inhibitors
por: Lee, Cheng-Chung, et al.
Publicado: (2007) -
Novel Triterpenic Acid—Benzotriazole Esters Act as Pro-Apoptotic Antimelanoma Agents
por: Mioc, Marius, et al.
Publicado: (2022) -
Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease
por: Shao, Yi-Ming, et al.
Publicado: (2008)